Concerning the central role of EGFR and PD-L1 in the pathogenesis and therapy of HNSCC, hypoxia-mediated modulation of receptor tyrosine kinase signaling or the immunologic status might represent another paradigm for therapy resistance mediated by tumor microenvironmental traits. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.